Taoyang Chen

5.3k total citations
93 papers, 3.5k citations indexed

About

Taoyang Chen is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Taoyang Chen has authored 93 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 32 papers in Epidemiology and 28 papers in Cancer Research. Recurrent topics in Taoyang Chen's work include Hepatitis B Virus Studies (27 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis C virus research (19 papers). Taoyang Chen is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis C virus research (19 papers). Taoyang Chen collaborates with scholars based in China, United States and Denmark. Taoyang Chen's co-authors include Jinjun Li, Ming Yao, Chao Ge, Fangyu Zhao, Xianghuo He, Hong Li, Jianren Gu, Yingjun Zhao, Hua Tian and Shenglin Huang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Taoyang Chen

92 papers receiving 3.5k citations

Peers

Taoyang Chen

EPIDE

ONCOL

HEPAT

Wen Yang China

Le‐Xing Yu China

Krista A. Zanetti United States

Junfang Ji China

Tong Wu United States

Henning Schulze‐Bergkamen Germany

Hayato Hikita Japan

Rongcheng Luo China

Hong‐Yang Wang China

Luca Quagliata Switzerland

Wen Yang China

Taoyang Chen

2.0k ×0.9

1.2k ×0.8

432 ×0.7

EPIDE

887 ×1.4

ONCOL

457 ×0.8

HEPAT

Citations per year, relative to Taoyang Chen Taoyang Chen (= 1×) peers Wen Yang

Countries citing papers authored by Taoyang Chen

Since Specialization

Citations

This map shows the geographic impact of Taoyang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taoyang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taoyang Chen more than expected).

Fields of papers citing papers by Taoyang Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taoyang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taoyang Chen. The network helps show where Taoyang Chen may publish in the future.

Co-authorship network of co-authors of Taoyang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Taoyang Chen. A scholar is included among the top collaborators of Taoyang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taoyang Chen. Taoyang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Xinge, et al.. (2024). NR4A3 inhibits the tumor progression of hepatocellular carcinoma by inducing cell cycle G0/G1 phase arrest and upregulation of CDKN2AIP expression. International Journal of Biological Sciences. 20(15). 5850–5867. 2 indexed citations

Jin, Wenjiao, Yang Su, Hechun Lin, et al.. (2023). Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma. International Journal of Biological Sciences. 19(7). 2270–2288. 12 indexed citations

Cao, Maomao, Lingling Lu, Chunsun Fan, et al.. (2022). Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 years. Cancer Letters. 536. 215652–215652. 21 indexed citations

Chen, Xiaoxia, Lili Zhang, Xianxian Li, et al.. (2022). STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1. Oncogene. 41(17). 2492–2504. 13 indexed citations

Zhou, Qingqing, Wei Tian, Zhiyuan Jiang, et al.. (2020). A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma. Cancer Research. 81(5). 1361–1374. 76 indexed citations

Zhang, Lili, Chao Ge, Fangyu Zhao, et al.. (2020). ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma. Cancer Research. 80(12). 2599–2611. 39 indexed citations

Wang, Jialin, Ting Zhang, Song Zhang, et al.. (2020). TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy. Liver International. 40(11). 2834–2847. 23 indexed citations

Minko, Irina G., Vladimir L. Vartanian, Paweł Jaruga, et al.. (2019). Characterization of rare NEIL1 variants found in East Asian populations. DNA repair. 79. 32–39. 15 indexed citations

Chen, Jing, Chao Ge, Fangyu Zhao, et al.. (2019). <p>CD24 isoform a promotes cell proliferation, migration and invasion and is downregulated by EGR1 in hepatocellular carcinoma</p>. OncoTargets and Therapy. Volume 12. 1705–1716. 22 indexed citations

10.

Song, Zhen, Tengfei Liu, Jing Chen, et al.. (2019). HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib. Cancer Letters. 460. 96–107. 55 indexed citations

11.

Qu, Chunfeng, Taoyang Chen, Yuting Wang, et al.. (2018). [Primary prevention model of liver cancer in rural China].. PubMed. 40(7). 481–489. 3 indexed citations

12.

Chen, Taoyang, Gengsun Qian, Chunsun Fan, et al.. (2018). Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer. Hepatoma Research. 4(1). 4–4. 14 indexed citations

13.

Liu, Yiyao, Chao Ge, Hua Tian, et al.. (2017). The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.. PubMed Central. 7(6). 1285–1297. 19 indexed citations

14.

Chen, Taoyang, Chunfeng Qu, Lingling Lu, et al.. (2016). [Long-term efficacy of neonatal hepatitis B vaccination against chronic hepatitis B virus infection and chronic liver disease: a cross-sectional study based on Qidong Hepatitis B Intervention Study].. PubMed. 37(1). 64–7. 1 indexed citations

15.

Hou, Helei, Hefen Sun, Ping Lü, et al.. (2013). Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 12(12). 2874–2884. 56 indexed citations

16.

Qu, Lishuai, et al.. (2013). Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Young Age Hepatocellular Carcinoma in Qidong, China. PLoS ONE. 8(3). e59583–e59583. 22 indexed citations

17.

Zhang, Lixing, Hefen Sun, Fangyu Zhao, et al.. (2012). BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma. Cancer Research. 72(16). 4276–4285. 82 indexed citations

18.

Bai, Xin, Yu Zhu, Gengsun Qian, et al.. (2010). Correlation of the mutations in n terminal of hepatitis B virus X protein with tumorigenesis of hepatocellular carcinoma.. Tumori. 30(5). 433–437. 1 indexed citations

19.

Chen, Taoyang. (2010). A Prospective Study of the Relationship between Hepatitis B Virus Markers and Primary Liver Cancer. 1 indexed citations

20.

Chen, Taoyang, et al.. (2006). The effect of selenium intake on the risk of liver cancer of HBsAg carriers: a cohort study. Tumori. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact